Atlas Trials

Artemisinin Partial Resistance in Ethiopian Plasmodium Falciparum: A Multisite Clinical, Molecular and In Vitro Study

Clinical trial NCT07527182 · COMPLETED

Trial details

NCT number
NCT07527182
Sponsor
Didier Menard
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Malaria (Plasmodium Falciparum)Drug ResistanceArtemisinin-resistantEthiopia
Start date
2024-05-01
Primary completion
2025-10-30
Enrollment
277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.